MyAverix Finance
US · Healthcare
Santen Pharmaceutical Co. Ltd (SNPHF)
Drug Manufacturers - General
Santen Pharmaceutical Co. Ltd (SNPHF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-30, reported market cap is $3.54B, P/E ratio is 18.95, net margin is 10.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SNPHF
Santen Pharmaceutical Co. Ltd (SNPHF) — FAQ
What is Santen Pharmaceutical Co. Ltd's market cap?
Santen Pharmaceutical Co. Ltd (SNPHF) has a reported market cap of $3.54B (data as of 2026-03-30).
What is SNPHF's P/E ratio?
The price-to-earnings (P/E) ratio for Santen Pharmaceutical Co. Ltd (SNPHF) is 18.95 (data as of 2026-03-30).
Does Santen Pharmaceutical Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Santen Pharmaceutical Co. Ltd (SNPHF). Check the MyAverix Finance app for the latest dividend data.
What sector is Santen Pharmaceutical Co. Ltd in?
Santen Pharmaceutical Co. Ltd (SNPHF) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is SNPHF listed on?
SNPHF is listed on US.
What is Santen Pharmaceutical Co. Ltd's net margin?
Santen Pharmaceutical Co. Ltd (SNPHF) reports a net margin of 10.6% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.